Loading organizations...
§ Venture Capital · Shanghai, China
Investment firm with a focus on technology, media, and telecommunications sectors, seeking opportunities within these industries.
GP TMT Capital operates as an organization whose specific activities and primary geographic base are not publicly detailed within available market intelligence. Public records do not disclose its precise business model, target sectors, or the nature of its customer engagements, making its operational focus difficult to ascertain. Key financial metrics, such as assets under management, total funding raised, or any reported valuation, are not publicly reported or verifiable. Similarly, no prominent lead investors, identifiable portfolio companies, or significant customers are publicly associated with GP TMT Capital in industry databases. The organization's foundational details, including its establishment year and the names of its founders, also remain undisclosed in public domain information. This limited public profile suggests a private operational approach, with comprehensive data on its market presence currently unavailable.
GP TMT Capital has 1 tracked investment across 1 company. The latest tracked deal is $55.0M Series C in MicuRx Pharmaceuticals in September 2016.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Sep 26, 2016 | MicuRx Pharmaceuticals | $55.0M Series C | GP Capital | 3E Bioventures Capital, Delian Capital |